These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 33846436)

  • 1. Key biomarkers within the colorectal cancer related inflammatory microenvironment.
    Calu V; Ionescu A; Stanca L; Geicu OI; Iordache F; Pisoschi AM; Serban AI; Bilteanu L
    Sci Rep; 2021 Apr; 11(1):7940. PubMed ID: 33846436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of Immune-Related and Inflammatory Markers and Their Prognostic Impact in Colorectal Cancer Patients.
    An S; Kim SK; Kwon HY; Kim CS; Bang HJ; Do H; Kim B; Kim K; Kim Y
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between chemokines CCL2, CCL3, and CCL4 with the tumor microenvironment and tumor-associated macrophage markers in colorectal cancer.
    De la Fuente López M; Landskron G; Parada D; Dubois-Camacho K; Simian D; Martinez M; Romero D; Roa JC; Chahuán I; Gutiérrez R; Lopez-K F; Alvarez K; Kronberg U; López S; Sanguinetti A; Moreno N; Abedrapo M; González MJ; Quera R; Hermoso-R MA
    Tumour Biol; 2018 Nov; 40(11):1010428318810059. PubMed ID: 30419802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between
    Proença MA; Biselli JM; Succi M; Severino FE; Berardinelli GN; Caetano A; Reis RM; Hughes DJ; Silva AE
    World J Gastroenterol; 2018 Dec; 24(47):5351-5365. PubMed ID: 30598580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis.
    Wei C; Yang C; Wang S; Shi D; Zhang C; Lin X; Liu Q; Dou R; Xiong B
    Mol Cancer; 2019 Mar; 18(1):64. PubMed ID: 30927925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and secretion of the pro‑inflammatory cytokine IL‑8 is increased in colorectal cancer cells following the knockdown of non‑erythroid spectrin αII.
    Ackermann A; Lafferton B; Plotz G; Zeuzem S; Brieger A
    Int J Oncol; 2020 Jun; 56(6):1551-1564. PubMed ID: 32236629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune cell concentrations among the primary tumor microenvironment in colorectal cancer patients predicted by clinicopathologic characteristics and blood indexes.
    Guo G; Wang Y; Zhou Y; Quan Q; Zhang Y; Wang H; Zhang B; Xia L
    J Immunother Cancer; 2019 Jul; 7(1):179. PubMed ID: 31300050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value of calprotectin S100A8/A9 complex as a biomarker in colorectal cancer: A systematic review.
    Moris D; Spartalis E; Angelou A; Margonis GA; Papalambros A; Petrou A; Athanasiou A; Schizas D; Dimitroulis D; Felekouras E
    J BUON; 2016; 21(4):859-866. PubMed ID: 27685906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of RAS mutations on the immune infiltrate of colorectal liver metastases: A preliminary study.
    Polidoro MA; Milana F; Soldani C; Franceschini B; Anselmo A; Colombo FS; Di Tommaso L; Cimino M; Carnevale S; Lleo A; Jaillon S; Torzilli G; Donadon M
    J Leukoc Biol; 2020 Aug; 108(2):715-721. PubMed ID: 32108374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction with tumor‑associated macrophages promotes PRL‑3‑induced invasion of colorectal cancer cells via MAPK pathway‑induced EMT and NF‑κB signaling‑induced angiogenesis.
    Zhang T; Liu L; Lai W; Zeng Y; Xu H; Lan Q; Su P; Chu Z
    Oncol Rep; 2019 May; 41(5):2790-2802. PubMed ID: 30864736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD163 as a Biomarker in Colorectal Cancer: The Expression on Circulating Monocytes and Tumor-Associated Macrophages, and the Soluble Form in the Blood.
    Krijgsman D; De Vries NL; Andersen MN; Skovbo A; Tollenaar RAEM; Møller HJ; Hokland M; Kuppen PJK
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32824692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and histopathological correlations of fecal calprotectin release in colorectal carcinoma.
    Lehmann FS; Trapani F; Fueglistaler I; Terracciano LM; von Flüe M; Cathomas G; Zettl A; Benkert P; Oertli D; Beglinger C
    World J Gastroenterol; 2014 May; 20(17):4994-9. PubMed ID: 24803811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The inflammatory microenvironment in colorectal neoplasia.
    McLean MH; Murray GI; Stewart KN; Norrie G; Mayer C; Hold GL; Thomson J; Fyfe N; Hope M; Mowat NA; Drew JE; El-Omar EM
    PLoS One; 2011 Jan; 6(1):e15366. PubMed ID: 21249124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the role of IL-35 in colorectal cancer progression and prognosis.
    Zeng JC; Zhang Z; Li TY; Liang YF; Wang HM; Bao JJ; Zhang JA; Wang WD; Xiang WY; Kong B; Wang ZY; Wu BH; Chen XD; He L; Zhang S; Wang CY; Xu JF
    Int J Clin Exp Pathol; 2013; 6(9):1806-16. PubMed ID: 24040445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA SATB2-AS1 inhibits tumor metastasis and affects the tumor immune cell microenvironment in colorectal cancer by regulating SATB2.
    Xu M; Xu X; Pan B; Chen X; Lin K; Zeng K; Liu X; Xu T; Sun L; Qin J; He B; Pan Y; Sun H; Wang S
    Mol Cancer; 2019 Sep; 18(1):135. PubMed ID: 31492160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel tumor-based epithelial-to-mesenchymal transition score that associates with prognosis and metastasis in patients with Stage II/III colorectal cancer.
    Roseweir AK; Kong CY; Park JH; Bennett L; Powell AGMT; Quinn J; van Wyk HC; Horgan PG; McMillan DC; Edwards J; Roxburgh CS
    Int J Cancer; 2019 Jan; 144(1):150-159. PubMed ID: 29992570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CPEB3 inhibits epithelial-mesenchymal transition by disrupting the crosstalk between colorectal cancer cells and tumor-associated macrophages via IL-6R/STAT3 signaling.
    Zhong Q; Fang Y; Lai Q; Wang S; He C; Li A; Liu S; Yan Q
    J Exp Clin Cancer Res; 2020 Jul; 39(1):132. PubMed ID: 32653013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated AA/EPA Ratio Represents an Inflammatory Biomarker in Tumor Tissue of Metastatic Colorectal Cancer Patients.
    Tutino V; De Nunzio V; Caruso MG; Veronese N; Lorusso D; Di Masi M; Benedetto ML; Notarnicola M
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31027294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the local immune status between the primary and metastatic tumor in colorectal cancer: a retrospective study.
    Shibutani M; Maeda K; Nagahara H; Fukuoka T; Matsutani S; Kashiwagi S; Tanaka H; Hirakawa K; Ohira M
    BMC Cancer; 2018 Apr; 18(1):371. PubMed ID: 29614981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinase 2 promotes cell growth and invasion in colorectal cancer.
    Dong W; Li H; Zhang Y; Yang H; Guo M; Li L; Liu T
    Acta Biochim Biophys Sin (Shanghai); 2011 Nov; 43(11):840-8. PubMed ID: 21968416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.